Mesa Laboratories, Inc. Share Price
Stocks
MLAB
US59064R1095
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 97.50 USD | -3.42% |
|
-0.45% | +24.20% |
| Market Cap | 55Cr 48Cr 45Cr 41Cr 77Cr 5.25TCr 78Cr 529.19Cr 206.75Cr 2.58TCr 204.82Cr 200.4Cr 8.93TCr | P/E 2027 * |
71.7x | P/E 2028 * | 45.5x |
|---|---|---|---|---|---|
| Enterprise Value | 55Cr 48Cr 45Cr 41Cr 77Cr 5.25TCr 78Cr 529.19Cr 206.75Cr 2.58TCr 204.82Cr 200.4Cr 8.93TCr | EV / Sales 2027 * |
2.11x | EV / Sales 2028 * | 2x |
| Free-Float |
94.59% | Yield 2027 * |
0.66% | Yield 2028 * | 0.66% |
Last Transcript: Mesa Laboratories, Inc.
| 1 day | -3.42% | ||
| 1 week | -0.45% | ||
| Current month | -2.06% | ||
| 1 month | +3.23% | ||
| 3 months | -0.47% | ||
| 6 months | +17.95% | ||
| Current year | +24.20% |
| 1 week | 94.1 |  | 102.52 |
| 1 month | 90 | | 107.68 |
| Current year | 71.06 | | 113.99 |
| 1 year | 55.45 | | 113.99 |
| 3 years | 55.45 | | 155.12 |
| 5 years | 55.45 | | 333.42 |
| 10 years | 55.45 | | 333.42 |
| Manager | Title | Age | Since |
|---|---|---|---|
Siddhartha Kadia
CEO | Chief Executive Officer | 57 | 12/04/2026 |
John Sakys
DFI | Director of Finance/CFO | 58 | 29/10/2012 |
Lyndsey Crennen
AUD | Comptroller/Controller/Auditor | 41 | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
John Sullivan
CHM | Chairman | 73 | 01/09/2017 |
Jennifer Alltoft
BRD | Director/Board Member | 58 | 04/03/2019 |
Shannon Hall
BRD | Director/Board Member | 57 | 11/05/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 22/06/26 | Sell | Controller/Auditor | -442 | 0.0080% | ||
| 22/06/26 | Sell | Executive/Senior Manager | -2,516 | 0.0455% | ||
| 22/06/26 | Sell | Chief Financial Officer | -2,827 | 0.0512% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.42% | -0.45% | +31.17% | -22.55% | 54Cr | |
| +2.29% | +2.36% | -17.97% | -10.09% | 18TCr | |
| +1.46% | +0.01% | -9.87% | -6.25% | 11TCr | |
| +1.58% | +0.65% | +6.69% | +61.86% | 6.03TCr | |
| -1.13% | -2.60% | +26.37% | +54.76% | 5.02TCr | |
| +2.22% | -1.14% | -14.85% | -44.15% | 4.31TCr | |
| +2.98% | -2.61% | - | - | 3.28TCr | |
| +1.50% | -6.67% | -17.52% | -43.99% | 2.76TCr | |
| -7.67% | -8.39% | +17.59% | -12.73% | 2.31TCr | |
| +1.63% | -1.73% | -5.80% | -7.80% | 2.09TCr | |
| Average | +0.14% | -2.06% | +1.76% | -3.44% | 5.44TCr | |
| Weighted average by Cap. | +1.28% | -0.40% | -6.59% | +0.81% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 26Cr 23Cr 21Cr 19Cr 36Cr 2.5TCr 37Cr 251.37Cr 98Cr 1.23TCr 97Cr 95Cr 4.24TCr | 27Cr 24Cr 22Cr 20Cr 38Cr 2.62TCr 39Cr 263.98Cr 103.13Cr 1.29TCr 102.17Cr 100Cr 4.46TCr |
| Net income | 75.67L 66.46L 61.8L 56.71L 1.07Cr 73Cr 1.08Cr 7.34Cr 2.87Cr 36Cr 2.84Cr 2.78Cr 123.86Cr | 1.21Cr 1.07Cr 99.11L 90.94L 1.71Cr 116.85Cr 1.74Cr 12Cr 4.6Cr 57Cr 4.55Cr 4.46Cr 198.62Cr |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24/26/24 | $97.50 | -3.42% | 1,20,894 |
| 23/26/23 | $100.95 | +2.41% | 1,66,556 |
| 22/26/22 | $98.57 | +1.09% | 1,34,820 |
| 21/26/21 | $97.51 | +0.87% | 1,16,535 |
| 20/26/20 | $96.67 | -1.30% | 1,37,800 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MLAB Stock
Select your edition
All financial news and data tailored to specific country editions
